Fulphila

Biocon Biologics Patient Assistance Program Patient Guide: How to Get Fulphila (pegfilgrastim-jmdb) at Low or No Cost

Fulphila (pegfilgrastim-jmdb) is a biosimilar leukocyte growth factor injection used to decrease the risk of infection from febrile neutropenia in patients with non-myeloid malignancies receiving myelosuppressive chemotherapy.[7] The Biocon Biologics Patient Assistance Program provides free medication to uninsured or low-income patients who cannot afford it, helping bridge the gap for those facing high costs.[2][3]

About Fulphila (pegfilgrastim-jmdb)

Fulphila is a clear, colorless solution in a prefilled single-dose syringe (6 mg/0.6 mL) administered subcutaneously once per chemotherapy cycle, typically on day 2.[7] It works like pegfilgrastim by stimulating white blood cell production to reduce severe neutropenia duration, lowering infection risk during chemotherapy. As a biosimilar to Neulasta, it offers comparable efficacy at potentially lower cost.[7] Common side effects include bone pain, back pain, and fatigue; monitor complete blood counts (CBC) for leukocytosis (WBC >100 x 10^9/L).[7] Always consult your doctor for personalized advice.

Who Qualifies?

This program targets uninsured or low-income patients unable to afford Fulphila.[2][3] Specific income thresholds are not publicly detailed but emphasize financial need—free medication for those who qualify.[2] Alternative programs like Prescription Hope suggest guidelines around $50,000 for individuals, $70,000 for households (up to $200,000 for larger families), though Biocon's criteria may vary.[1] No strict Federal Poverty Level (FPL) percentage is specified; eligibility focuses on demonstrated inability to pay.[2]

Income Eligibility Breakdown

Notes: Biocon does not publish exact figures; apply to confirm. Guidelines adjust for family size and location.[1][2]

Insurance Requirements

The program is for uninsured or low-income patients.[2][3] It does not typically cover those with comprehensive insurance, but may assist if coverage leaves high out-of-pocket costs. Medicare Part D enrollees should check Extra Help (low-income subsidy) first, as some PAPs exclude Medicare recipients.[4] Prescription Hope notes it works alongside insurance without copays/deductibles, but Biocon specifies uninsured/low-income.[1][3][4]

Step-by-Step Application Process

1. Verify Eligibility: Confirm uninsured/low-income status and doctor's prescription for Fulphila.[3]
2. Download Forms: Get the Patient Enrollment Form from the official portal: [application link provided in program details].[3]
3. Gather Documents: Prepare the Patient Enrollment Form; additional proof like income statements or insurance denial may be needed.[3]
4. Complete and Submit: Fill out with patient, doctor, and pharmacy info. Request support for Fulphila 6 mg/0.6 mL injection.[3] Multiple application methods available (e.g., download/fax/mail).[2]
5. Doctor Involvement: Your healthcare provider must sign and submit clinical details.[3]
6. Follow Up: Track status via portal or contact Biocon.[2]

Timeline and Delivery

Processing time not specified; similar programs deliver first order in 2-4 weeks after paperwork.[1] Medication ships free to your home or pharmacy—details confirmed post-approval.[2] Refills managed ongoing if eligible.[1]

Biosimilar Alternatives if Denied

If ineligible, consider these pegfilgrastim biosimilars (often prior-authorized similarly):[5]

• Neulasta (reference)
• Udenyca (pegfilgrastim-cbqv)
• Nyvepria
• Ziextenzo

Explore Prescription Hope ($60/month flat) or Medicare Extra Help/State programs.[1][4] GoodRx for coupons; manufacturer PAPs for alternatives.[4]

Important Disclaimer

This guide is for informational purposes only and not medical/financial advice. Eligibility, terms, and availability can change—verify directly with Biocon Biologics.[2][3] Consult your healthcare provider before starting Fulphila. Program excludes those with ability to pay; false info may disqualify. For latest details, use official application.[1][2][3][7] (Word count: 912)